Boehringer Ingelheim’s COPD and asthma inhalers are now available for $35 a month for eligible patients

Boehringer’s first-of-its-kind program automatically reduces the costs of its COPD and asthma inhalers at the pharmacy counter for vast majority of eligible patients Program provides predictable, affordable and consistent costs for as many patients as possible, including uninsured…